Abingdon Health PLC
LSE:ABDX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Abingdon Health PLC
LSE:ABDX
|
UK |
|
O
|
Ostim Endustriyel Yatirimlar ve Isletme AS
IST:OSTIM.E
|
TR |
|
I
|
Intchains Group Ltd
NASDAQ:ICG
|
CN |
|
S
|
Sanko Gosei Ltd
TSE:7888
|
JP |
|
A
|
Accor SA
OTC:ACCYY
|
FR |
|
Hub Cyber Security Ltd
NASDAQ:HUBC
|
IL |
|
Victory Securities (Holdings) Company Ltd
HKEX:8540
|
HK |
|
Taiba Investments Company SJSC
SAU:4090
|
SA |
|
Chongqing Sansheng Industrial Co Ltd
SZSE:002742
|
CN |
|
G
|
Gansu Guofang Industry & Trade Group Ltd by Share Ltd
SSE:601086
|
CN |
|
S
|
Sanghvi Movers Ltd
NSE:SANGHVIMOV
|
IN |
|
Ichia Technologies Inc
TWSE:2402
|
TW |
Abingdon Health PLC
Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).
Abingdon Health Plc develops, manufactures and commercializes immunoassay tests and reader systems. The company is headquartered in York, North Yorkshire and currently employs 151 full-time employees. The company went IPO on 2020-12-15. The firm operates through three segments: Contract Development, Contract Manufacturing and Product Sales. The Contract Development segment comprises development work for third parties and is recognized over time based on a proportion of completion. The Contract Manufacturing segment comprises contract development and manufacturing activities. The Product Sales segment comprises the sale of ABC-19, pocket diagnostic products, progressive rod cone degeneration (PCRD) tests and antibodies for research use. Its products also include Seralite, which includes Free Light Chain (FLC) Serum. The Company’s geographical market include the United Kingdom, the United States/Canada, rest of world (ROW).
This earnings call has not been analyzed yet.
If you’d like us to analyze this earnings call, click the "Request Earnings Call Analysis" button below.
